Pfizer
UEI: MHBQULRMEEJ5
• CAGE: 86491
Overview
Awardee Type
Parent
(17 children)
Company Description
Discover the commonalities and differences between biologics vs. biosimilars — especially when it comes to cost.
Name
Pfizer
Website
Headquarters
New York, NY
United States
United States
Ownership
Publicly Traded (NYSE:PFE)
Most Recent Award
April 1, 2025
Calculating
Federal contract and grant recipient
PFIZER INC
(UEI MHBQULRMEEJ5, CAGE 86491)
is headquartered in New York NY.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in June 1942 and
federally registered in
January 2002.
Federal Award Analysis
Pfizer federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Year | Contracts | Subcontracts | Grants | Subgrants |
---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PFIZER INC
UEI
MHBQULRMEEJ5
CAGE Code
86491
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 2, 1942
Initial Registration
Jan. 30, 2002
Last Registration
Feb. 13, 2025
Registration Activation
Aug. 15, 2024
Registration Expiration
Aug. 13, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Publicly Traded
Manufacturer of Goods
Publicly Traded
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Pfizer
GSA Schedules and Price Lists
- Pfizer
- PoP: 6/30/24 - 6/30/29
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $2,151,230
- Pfizer
- PoP: 3/18/03 - 12/31/99
- Obligated: $159,180
- Global Blood Therapeutics
- PoP: 7/14/20 - 12/31/23 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $176,907
- Global Blood Therapeutics
- PoP: 3/3/20 - 7/15/20 (Ended)
- Obligated: $0
- Array Biopharma
- PoP: 4/30/19 - 6/30/24 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Pfizer
- PoP: 10/31/14 - 6/30/24 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $4,590,542
- Hospira Worldwide
- PoP: 9/30/14 - 6/30/24 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $797,475
Contract Vehicles
Pfizer multi-award contract vehicles
IDV Awards
Pfizer indefinite delivery vehicle awards
Contract Awards
Pfizer prime contract awards
Subcontract Awards
Pfizer subcontract awards
Grant Awards
Pfizer direct grants
Subgrant Awards
Pfizer subgrant awards
State and Local Awards
Pfizer state and local contract awards
Click here to learn more about State and Local award data coverageApproved Supplier
CAGE 86491 Defense Logistics Agency approved NSNs
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Pfizer
Additional Analysis
Federal Contract Opportunities Requiring Similar Experience
State and Local Opportunities Requiring Similar Experience
Top Contracting Officers Buying from Awardee
Federal Contracts Recompeting Soon
Federal Grants Recompeting Soon
Market Size Analysis
Active Federal Opportunities for Registered NAICS
State and Local Opportunities Requiring Similar Experience
Top Contracting Officers Buying from Awardee
Federal Contracts Recompeting Soon
Federal Grants Recompeting Soon
Market Size Analysis
Active Federal Opportunities for Registered NAICS